{"id":2019,"date":"2026-05-28T21:13:50","date_gmt":"2026-05-28T19:13:50","guid":{"rendered":"https:\/\/www.oncovirlab.hr\/?p=2019"},"modified":"2026-06-29T09:34:11","modified_gmt":"2026-06-29T07:34:11","slug":"professional-symposium-oncolytic-virotherapy","status":"publish","type":"post","link":"https:\/\/www.oncovirlab.hr\/en\/strucni-simpozij-onkoliticka-viroterapija\/","title":{"rendered":"Scientific\/expert symposium"},"content":{"rendered":"

Oncolytic virotherapy in modern cancer treatment<\/h3>\n

From research to clinical application<\/em><\/p>\n

June 11, 2026.
\nSchool of Public Health \u201cAndrija \u0160tampar\u201d Rockefeller Street 4, Zagreb, Croatia
\nStart at 2:00 PM<\/strong><\/p>\n

As part of the project \u201cDevelopment of Oncolytic Virotherapy for Cancer Treatment in Animals\u201d<\/strong>, the University of Zagreb and the Centre of Excellence for Viral Immunology and Vaccines, in cooperation with the Croatian Academy of Medical Sciences and the Andrija \u0160tampar School of Public Health, are organizing a scientific\/expert symposium dedicated to modern approaches in oncolytic virotherapy and its clinical application. The symposium brings together national and international experts in virology, oncology, immunotherapy, and translational medicine, with the aim of presenting current scientific and clinical insights into the application of oncolytic viruses in the treatment of malignant diseases.<\/p>\n

The event is intended for physicians, researchers, representatives of the healthcare and scientific sectors, and all those interested in the development of innovative therapeutic approaches in oncology.<\/p>\n

Please find the program below this invitation.<\/p>\n

Please find the original announcement HERE (croatian) <\/a><\/span>\/<\/span> HERE (eng)<\/a>.<\/span><\/span><\/strong><\/p>\n

We look forward to welcoming you!<\/p>\n

 <\/p>\n

Sincerely,<\/p>\n

Organizing Committee<\/p>\n

 <\/p>\n

Speakers<\/h3>\n

\"\"Prof. Dr. med. dr. rer. nat. Guy Ungerechts <\/strong>\/<\/strong> CV<\/span>
\n<\/strong><\/a>German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg<\/p>\n

Lecture title: <\/strong>Immunovirotherapy \u2013 Clinical translation<\/em><\/strong><\/p>\n

Various early clinical trials with oncolytic viral vectors including Measles virus (MeV) for the treatment of different cancer types have been completed. To engineer next generation MeV vectors for more efficient immunovirotherapy we encoded various immunomodulators including immune checkpoint inhibitors (e. g. anti-PD1), bispecific T cell engagers (BiTEs), cytokines (e. g. IL-12), as well as tumor associated antigens (TAA) for monotherapy, and to explore combination with adoptive cell transfer (ACT) approaches. MeV-IL12 is our lead candidate for clinical translation and GMP manufacturing is currently ongoing. A phase I\/II dose escalation trial in patients with advanced\/metastasized solid tumour\u2019s will be launched next year. Upfront, we treated four patients within an early clinical access program.<\/p>\n

\u00a0<\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

\"\"<\/strong><\/p>\n

Dr. sc. Beata Halassy <\/strong>\/ CV<\/a><\/span><\/strong>
\n<\/strong>University of Zagreb, Centre for Research and Knowledge Transfer in Biotechnology<\/p>\n

Lecture title: <\/strong>Oncolytic viruses as ex tempore, point-of-care preparations<\/em><\/strong><\/p>\n

Oncolytic virotherapy uses viruses as anticancer agents capable of selectively infecting and destroying malignant cells. Despite promising clinical potential, the translation of oncolytic viruses into routine clinical use remains limited by complex regulatory and manufacturing requirements. As an alternative approach, based on experience from successful experimental self-treatment1, we propose the development of ex tempore viral preparations manufactured at the point of care. The lecture will discuss the establishment of a detailed characterization framework to evaluate whether fresh viral preparations intended for immediate use can be reproducible, analytically well-defined, and clinically applicable. Emphasis will be placed on the potential of ex tempore oncolytic viruses as a novel medicinal product format and on their possible role in future personalized and precision-based cancer therapy approaches. 1For\u010di\u0107 et al. Vaccines 2024; 12:958<\/p>\n

 <\/p>\n

 <\/p>\n

\"\"<\/strong><\/p>\n

 <\/p>\n

Prof. Dr. Tihana Lenac Rovi\u0161 <\/strong>\/ CV<\/a><\/span>
\n<\/strong>Center for Proteomics, Faculty of Medicine, University of Rijeka, Croatia<\/p>\n

Lecture title:<\/strong> Development of novel nectin-based immunotherapies for cancer<\/em><\/strong><\/p>\n

Immune checkpoint inhibitors (ICIs) have demonstrated substantial clinical benefit in subsets of oncology patients; however, the majority of patients fail to respond due to diverse tumor immune evasion mechanisms. Among these, the poliovirus receptor (PVR, CD155) plays a role in suppressing anti-tumor immunity through multiple non-redundant pathways, including inhibitory signalling via TIGIT, CD96, and KIR2DL5A receptors. The lecture will present in vitro and in vivo studies dissecting the role of nectin family proteins and their receptors in tumor biology. We will discuss the development of novel antibody-based strategies, including anti-PVR monoclonal antibodies, and highlight their preclinical efficacy in restoring CD8\u207a T cell and NK cell function. Emphasis will be placed on PVR-targeted approaches, with focus on the translational development of the clinical-stage candidate NTX1088, currently being evaluated in early-phase clinical trials in combination with PD-1 blockade.<\/p>\n

\u00a0<\/em><\/p>\n

<\/h3>\n

PRELIMINARY SYMPOSIUM PROGRAM<\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
THURSDAY, JUNE 11, 2026\u00a0<\/strong><\/td>\n<\/tr>\n<\/thead>\n
TIME\u00a0<\/strong><\/td>\nTOPIC\u00a0<\/strong><\/td>\n<\/tr>\n
1330<\/sup> \u2013 1400<\/sup><\/strong><\/p>\n

Vestibule<\/strong><\/td>\n

REGISTRATION\u00a0<\/strong><\/td>\n<\/tr>\n
1400<\/sup> \u2013 1430<\/sup><\/strong><\/p>\n

Large Hall<\/strong><\/td>\n

OPENING CEREMONY<\/strong><\/td>\n<\/tr>\n
1430<\/sup> \u2013 1530<\/sup><\/strong><\/p>\n

Large Hall<\/strong><\/td>\n

PLENARY LECTURE<\/strong><\/p>\n

PROF. DR. MED. DR. RER. NAT. GUY UNGERECHTS <\/strong>\u00a0<\/strong><\/p>\n

Immunovirotherapy \u2013 Clinical translation<\/em><\/td>\n<\/tr>\n

1530<\/sup> \u2013 1600<\/sup><\/strong><\/p>\n

Vestibule\u00a0<\/strong><\/td>\n

COFFEE BREAK<\/strong><\/td>\n<\/tr>\n
1600<\/sup>\u2013 1630<\/sup><\/strong><\/p>\n

Large Hall\u00a0<\/strong><\/td>\n

BEATA HALASSY, MD, PhD<\/strong><\/p>\n

Oncolytic viruses as ex tempore, point-of-care preparations<\/em><\/p>\n

\u00a0<\/strong><\/td>\n<\/tr>\n

1630<\/sup> \u2013 1700<\/sup><\/strong><\/p>\n

Large Hall\u00a0<\/strong><\/td>\n

PROF.D.Sc. TIHANA LENAC ROVI\u0160<\/strong><\/p>\n

Development of novel nectin-based immunotherapies for cancer<\/em><\/td>\n<\/tr>\n

1700<\/sup> \u2013 1730<\/sup><\/strong><\/p>\n

Large Hall<\/strong><\/td>\n

ROUND TABLE<\/b><\/td>\n<\/tr>\n
1730<\/sup> \u2013 1830<\/sup><\/strong><\/p>\n

Vestibule\u00a0<\/strong><\/td>\n

Reception\u00a0<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

* the organizer reserves the right to change the symposium schedule<\/p>\n

<\/h3>\n

Registration<\/h3>\n

The symposium is free of charge; due to the limited number of participants, we kindly ask you to register via the following link or QR code: REGISTRATION LINK.<\/a><\/span><\/strong><\/p>\n

\"\"<\/p>\n

If you experience any difficulties with registration, please contact us at sravlic@unizg.hr.<\/a><\/p>\n

 <\/p>\n

Online participation<\/h3>\n

Participants who are unable to attend in person my join the symposium online via Zoom.
\nJoin Zoom Meeting: LINK<\/a><\/strong><\/span><\/p>\n

Meeting ID: 818 3650 2901
\nPassword: 236561<\/p>\n

<\/h3>\n

Organizing Committee<\/h3>\n

Sanda Ravli\u0107, Beata Halassy, Maja Lang Balija, Lucija Ivandi\u0107, Erika Gamulin, Anto Vrdoljak<\/p>\n

\u00a0<\/strong><\/p>\n

Official language of the scientific\/expert symposium<\/h3>\n

English<\/p>\n

<\/h3>\n

<\/h3>\n

Symposium Sponsor<\/h3>\n

\"\"<\/p>\n

LKB Vertriebs GmbH, Zagreb Branch
\nNew Road 103
\nHR-10000 Zagreb, Croatia<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

The Scientific\/Expert Symposium \u201cONCOLYTIC VIROTHERAPY IN MODERN CANCER TREATMENT\u201d will take place in Zagreb on 11 June 2026.<\/p>","protected":false},"author":1,"featured_media":2046,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-2019","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"yoast_head":"\nOnkoliti\u010dka viroterapija \u2013 stru\u010dni simpozij u Zagrebu<\/title>\n<meta name=\"description\" content=\"Stru\u010dni simpozij o onkoliti\u010dkoj viroterapiji odr\u017eava se 11. lipnja 2026. u Zagrebu. Tema je klini\u010dka primjena onkoliti\u010dkih virusa u lije\u010denju raka.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oncovirlab.hr\/en\/professional-symposium-oncolytic-virotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Znanstveno-stru\u010dni simpozij\" \/>\n<meta property=\"og:description\" content=\"Stru\u010dni simpozij o onkoliti\u010dkoj viroterapiji odr\u017eava se 11. lipnja 2026. u Zagrebu. Tema je klini\u010dka primjena onkoliti\u010dkih virusa u lije\u010denju raka.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oncovirlab.hr\/en\/professional-symposium-oncolytic-virotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T19:13:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T07:34:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"certumproadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"certumproadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/\"},\"author\":{\"name\":\"certumproadmin\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/person\\\/34782dea7df3484842cb2e9f4f3acc6e\"},\"headline\":\"Znanstveno-stru\u010dni simpozij\",\"datePublished\":\"2026-05-28T19:13:50+00:00\",\"dateModified\":\"2026-06-29T07:34:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/\"},\"wordCount\":612,\"publisher\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg\",\"articleSection\":[\"Vijesti\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/\",\"name\":\"Onkoliti\u010dka viroterapija \u2013 stru\u010dni simpozij u Zagrebu\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg\",\"datePublished\":\"2026-05-28T19:13:50+00:00\",\"dateModified\":\"2026-06-29T07:34:11+00:00\",\"description\":\"Stru\u010dni simpozij o onkoliti\u010dkoj viroterapiji odr\u017eava se 11. lipnja 2026. u Zagrebu. Tema je klini\u010dka primjena onkoliti\u010dkih virusa u lije\u010denju raka.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg\",\"contentUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg\",\"width\":1280,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/strucni-simpozij-onkoliticka-viroterapija\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.oncovirlab.hr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Znanstveno-stru\u010dni simpozij\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/\",\"name\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\",\"description\":\"Laboratorij za imunokemiju i biokemiju\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#organization\",\"name\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-Oncovirlab-Icon.webp\",\"contentUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-Oncovirlab-Icon.webp\",\"width\":512,\"height\":512,\"caption\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/person\\\/34782dea7df3484842cb2e9f4f3acc6e\",\"name\":\"certumproadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/litespeed\\\/avatar\\\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/litespeed\\\/avatar\\\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518\",\"contentUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/litespeed\\\/avatar\\\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518\",\"caption\":\"certumproadmin\"},\"sameAs\":[\"https:\\\/\\\/www.oncovirlab.hr\"],\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/author\\\/certumproadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Oncolytic virotherapy \u2013 expert symposium in Zagreb","description":"The expert symposium on oncolytic virotherapy will be held on June 11, 2026 in Zagreb. The topic is the clinical application of oncolytic viruses in the treatment of cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oncovirlab.hr\/en\/professional-symposium-oncolytic-virotherapy\/","og_locale":"en_US","og_type":"article","og_title":"Znanstveno-stru\u010dni simpozij","og_description":"Stru\u010dni simpozij o onkoliti\u010dkoj viroterapiji odr\u017eava se 11. lipnja 2026. u Zagrebu. Tema je klini\u010dka primjena onkoliti\u010dkih virusa u lije\u010denju raka.","og_url":"https:\/\/www.oncovirlab.hr\/en\/professional-symposium-oncolytic-virotherapy\/","og_site_name":"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji","article_published_time":"2026-05-28T19:13:50+00:00","article_modified_time":"2026-06-29T07:34:11+00:00","og_image":[{"width":1280,"height":960,"url":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg","type":"image\/jpeg"}],"author":"certumproadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"certumproadmin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#article","isPartOf":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/"},"author":{"name":"certumproadmin","@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/person\/34782dea7df3484842cb2e9f4f3acc6e"},"headline":"Znanstveno-stru\u010dni simpozij","datePublished":"2026-05-28T19:13:50+00:00","dateModified":"2026-06-29T07:34:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/"},"wordCount":612,"publisher":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#organization"},"image":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg","articleSection":["Vijesti"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/","url":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/","name":"Oncolytic virotherapy \u2013 expert symposium in Zagreb","isPartOf":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#primaryimage"},"image":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg","datePublished":"2026-05-28T19:13:50+00:00","dateModified":"2026-06-29T07:34:11+00:00","description":"The expert symposium on oncolytic virotherapy will be held on June 11, 2026 in Zagreb. The topic is the clinical application of oncolytic viruses in the treatment of cancer.","breadcrumb":{"@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#primaryimage","url":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg","contentUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2026\/05\/Skola_narodnog_zdravlja_Andrija_Stampar_040409.jpg","width":1280,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/www.oncovirlab.hr\/strucni-simpozij-onkoliticka-viroterapija\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oncovirlab.hr\/"},{"@type":"ListItem","position":2,"name":"Znanstveno-stru\u010dni simpozij"}]},{"@type":"WebSite","@id":"https:\/\/www.oncovirlab.hr\/en\/#website","url":"https:\/\/www.oncovirlab.hr\/en\/","name":"Center for Research and Knowledge Transfer in Biotechnology","description":"Laboratory for Immunochemistry and Biochemistry","publisher":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oncovirlab.hr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.oncovirlab.hr\/en\/#organization","name":"Center for Research and Knowledge Transfer in Biotechnology","url":"https:\/\/www.oncovirlab.hr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2025\/09\/cropped-Oncovirlab-Icon.webp","contentUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2025\/09\/cropped-Oncovirlab-Icon.webp","width":512,"height":512,"caption":"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji"},"image":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/person\/34782dea7df3484842cb2e9f4f3acc6e","name":"certumproadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oncovirlab.hr\/wp-content\/litespeed\/avatar\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518","url":"https:\/\/www.oncovirlab.hr\/wp-content\/litespeed\/avatar\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518","contentUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/litespeed\/avatar\/950f9d4f29bb944396d67e466317296b.jpg?ver=1783743518","caption":"certumproadmin"},"sameAs":["https:\/\/www.oncovirlab.hr"],"url":"https:\/\/www.oncovirlab.hr\/en\/author\/certumproadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/posts\/2019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/comments?post=2019"}],"version-history":[{"count":42,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/posts\/2019\/revisions"}],"predecessor-version":[{"id":2118,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/posts\/2019\/revisions\/2118"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/media\/2046"}],"wp:attachment":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/media?parent=2019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/categories?post=2019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/tags?post=2019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}